118 related articles for article (PubMed ID: 10069171)
21. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
Nevitt MC; Felson DT; Williams EN; Grady D
Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
[TBL] [Abstract][Full Text] [Related]
22. Optimizing the dose of hormone replacement therapy.
Rice VM
Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
[TBL] [Abstract][Full Text] [Related]
23. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
[TBL] [Abstract][Full Text] [Related]
24. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
25. Endometrial safety and bleeding with HRT: what's new?
Sturdee DW
Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
[TBL] [Abstract][Full Text] [Related]
26. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
27. Progestins initiate adverse events of menopausal estrogen therapy.
Thomas T; Rhodin J; Clark L; Garces A
Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of menopausal therapies on the endometrium.
Mirkin S; Archer DF; Taylor HS; Pickar JH; Komm BS
Menopause; 2014 Aug; 21(8):899-908. PubMed ID: 24518153
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
30. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
[TBL] [Abstract][Full Text] [Related]
31. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
32. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Flowers CE; Wilborn WH; Hyde BM
Obstet Gynecol; 1983 Feb; 61(2):135-43. PubMed ID: 6296742
[TBL] [Abstract][Full Text] [Related]
34. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
[No Abstract] [Full Text] [Related]
35. [Sexuality in menopause. Importance of adequate replacement therapy].
Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R
Minerva Ginecol; 1999 Mar; 51(3):59-62. PubMed ID: 10352535
[TBL] [Abstract][Full Text] [Related]
36. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
Benjamin I; Block RE
Obstet Gynecol; 1977 Aug; 50(2):136-8. PubMed ID: 876552
[TBL] [Abstract][Full Text] [Related]
37. Estrogen replacement therapy.
Acken HS
Obstet Gynecol; 1969 Jul; 34(1):46-9. PubMed ID: 4307194
[No Abstract] [Full Text] [Related]
38. [Hormone substitution with premarin plus. Results of an Austrian multicenter treatment study].
Kazar T; Neumann K; Windsteig E
Wien Med Wochenschr; 1995; 145(1):18-21. PubMed ID: 7771101
[TBL] [Abstract][Full Text] [Related]
39. [Estrogen therapy in postmenopause and cancer of the endometrium].
Clavero Núñez DJ
An R Acad Nac Med (Madr); 1991; 108(2):429-42. PubMed ID: 1767893
[No Abstract] [Full Text] [Related]
40. Progesterone and endometrial cancer.
Gompel A
Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
